A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

Background: Many studies have recently reported the association of concomitant medications with the response and survival in patients with non-small-cell lung cancer (NSCLC) treated with cancer immunotherapy. However, the clinical impact of statin therapy on the outcome of cancer immunotherapy in pa...

Full description

Bibliographic Details
Main Authors: Hamatake, M. (Author), Hirai, F. (Author), Inoue, K. (Author), Mori, M. (Author), Nakanishi, Y. (Author), Okamoto, I. (Author), Okamoto, T. (Author), Otsubo, K. (Author), Shimamatsu, S. (Author), Shimokawa, M. (Author), Tagawa, T. (Author), Takada, K. (Author), Takamori, S. (Author), Tanaka, K. (Author), Tsuchiya-Kawano, Y. (Author), Yoneshima, Y. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Nivolumab
Non-small-cell lung cancer
Pembrolizumab
Prognostic factor
Statin
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items